These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
153 related articles for article (PubMed ID: 9105118)
1. The perils of nontreatment of hyperuricemia. Hoffman GS Cleve Clin J Med; 1997 Apr; 64(4):215. PubMed ID: 9105118 [No Abstract] [Full Text] [Related]
2. A new standard of care? Studies on febuxostat in the management of hyperuricemia with and without gout. Kamatani N; Hosoya T J Clin Rheumatol; 2011 Jun; 17(4 Suppl 2):S11-2. PubMed ID: 21654264 [No Abstract] [Full Text] [Related]
3. Febuxostat : a viewpoint by Naomi Schlesinger. Schlesinger N Drugs; 2008; 68(13):1875-6. PubMed ID: 18729539 [No Abstract] [Full Text] [Related]
4. Febuxostat: a viewpoint by H. Ralph Schumacher Jr and Lan X. Chen. Schumacher HR; Chen LX Drugs; 2008; 68(13):1875-6. PubMed ID: 18729538 [No Abstract] [Full Text] [Related]
5. New therapeutic approach to hyperuricemia and gout in the light of recommendations. Lioté F Joint Bone Spine; 2016 Jul; 83(4):376-80. PubMed ID: 27085801 [No Abstract] [Full Text] [Related]
6. [Hyperuricemia: a laboratory finding needing treatment?]. Keller C Verh Dtsch Ges Inn Med; 1990; 96():188-92. PubMed ID: 2092438 [No Abstract] [Full Text] [Related]
7. Lesinurad/allopurinol (Duzallo) for gout-associated hyperuricemia. Med Lett Drugs Ther; 2017 Nov; 59(1533):182-183. PubMed ID: 29125593 [No Abstract] [Full Text] [Related]
8. [How to treat hyperuricemia and gout attacks in compensated kidney failure?]. Gröbner W Dtsch Med Wochenschr; 2002 Mar; 127(11):576. PubMed ID: 11894180 [No Abstract] [Full Text] [Related]
9. Febuxostat--treatment for hyperuricemia and gout? Moreland LW N Engl J Med; 2005 Dec; 353(23):2505-7. PubMed ID: 16339099 [No Abstract] [Full Text] [Related]
10. [Hyperuricemia and gout: therapeutic indications]. Pawlotsky Y Rev Prat; 1994 Jan; 44(2):206-9. PubMed ID: 8178077 [TBL] [Abstract][Full Text] [Related]